Wednesday, July 31, 2013

New Interest In The Antiaging Drug Gerovital H3

Over 30 years ago, the Food and Drug Administration (FDA) banned the antiaging drug Gerovital H3, siting the drug did not live up to its promise. suddenly it appears a new generation of people are showing interest in the drug, so what's special about Gerovital H3?

The Gerovital H3 was initiated in 1905 when Dr. Alfred Einhorn, a biochemist, combined two substances that occur naturally in the body: diethylaminoethanol (DEAE) and para-aminobenzoic acid (PABA), in a liquid. The drug, procaine hydrochloride, was solely used as a pain killer till the 1940s. This is where Dr. Ana Aslan of the National Geriatric Institute in Bucharest started giving the drug to some elderly patients with arthritis.

That’s when she discovered that the combination not only improved arthritis symptoms but enhanced other physical as well as mental abilities as well. However, the benefits were short-lived, so she added potassium metabisulphite and disodium phosphate, which extended the drug’s benefits for 6 to 9 hours. Gerovital H3 was born.

Aslan tested the drug in a large double-blind, placebo-controlled study with 15,000 workers throughout Romania. Researchers reported that those taking Gerovital H3 showed increased sex drive, disappearance of peptic ulcers, improvements in arthritis symptoms, better blood pressure and cholesterol levels, and other benefits.

There are of course many sceptics and it is not surprising as the drug is not yet approved by the FDA. But you got to ask your self how many other drugs in the market have many side effects and sometimes do not work for every one. So GH3 may well work for many people, as long as you take precautions and seek the advise of your medical practitioner.